NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank20
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-19.69
↓ 57% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
-12.50
Historical baseline
PeriodValueYoY Change
2025-19.69-96.2%
2024-10.04-93.5%
2023-5.19+43.2%
2022-9.13-120.5%
2021-4.14+84.6%
2020-26.82-